Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly and | Svizzera | Salute | Prodotti farmaceutici | 667,48 Mrd CHF | 107,7x | 8,17 | 750 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Roche Holding | Svizzera | Salute | Prodotti farmaceutici | 231,07 Mrd CHF | 20,4x | -6,34 | 289,40 CHF | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -1,2% Ribasso | Fai l’upgrade a Pro+ | |
Roche Holding Participation | Svizzera | Salute | Prodotti farmaceutici | 216,01 Mrd CHF | 21,8x | -6,34 | 270,60 CHF | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,2% Rialzo | Fai l’upgrade a Pro+ | |
Novartis | Svizzera | Salute | Prodotti farmaceutici | 196,91 Mrd CHF | 14,6x | 0,2 | 97,44 CHF | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Novartis | Svizzera | Salute | Prodotti farmaceutici | 196,91 Mrd CHF | 14,6x | 0,2 | 97,15 CHF | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 2,6% Rialzo | Fai l’upgrade a Pro+ | |
Abbott Laboratories | Svizzera | Salute | Attrezzature e forniture medicali | 166,02 Mrd CHF | 35,5x | 4,21 | 93,50 CHF | -2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Alcon | Svizzera | Salute | Attrezzature e forniture medicali | 41,58 Mrd CHF | 44,6x | 0,22 | 84,32 CHF | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,1% Rialzo | Fai l’upgrade a Pro+ | |
Lonza Group | Svizzera | Salute | Ricerca medica e biotecnologica | 38,89 Mrd CHF | 58x | -1,41 | 534,60 CHF | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17% Rialzo | Fai l’upgrade a Pro+ | |
Lonza Group | Svizzera | Salute | Ricerca medica e biotecnologica | 38,89 Mrd CHF | 58x | -1,41 | 534,60 CHF | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17% Rialzo | Fai l’upgrade a Pro+ | |
Straumann Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 21,99 Mrd CHF | 81,1x | -2,75 | 138,25 CHF | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,7% Rialzo | Fai l’upgrade a Pro+ | |
Zimmer Biomet Holdings Inc | Svizzera | Salute | Attrezzature e forniture medicali | 18,50 Mrd CHF | 22,3x | 0,22 | 109 CHF | -3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sonova Holding | Svizzera | Salute | Attrezzature e forniture medicali | 18,05 Mrd CHF | 26,3x | -4,81 | 228,60 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sonova H Ag | Svizzera | Salute | Attrezzature e forniture medicali | 18,05 Mrd CHF | 30,2x | -4,81 | 303,80 CHF | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -4,6% Ribasso | Fai l’upgrade a Pro+ | |
Sandoz | Svizzera | Salute | Prodotti farmaceutici | 15,13 Mrd CHF | -2.379,2x | 22,21 | 35,27 CHF | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,4% Rialzo | Fai l’upgrade a Pro+ | |
Ypsomed Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 5,64 Mrd CHF | 72x | 1,43 | 412 CHF | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,2% Rialzo | Fai l’upgrade a Pro+ | |
BACHEM HOLDING AG | Svizzera | Salute | Ricerca medica e biotecnologica | 5,36 Mrd CHF | 47x | 3,26 | 71,20 CHF | -2,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,3% Rialzo | Fai l’upgrade a Pro+ | |
Siegfried Holding Ltd | Svizzera | Salute | Prodotti farmaceutici | 4,88 Mrd CHF | 37,7x | -2,64 | 1.138 CHF | -1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,7% Rialzo | Fai l’upgrade a Pro+ | |
Galenica Sante | Svizzera | Salute | Prodotti farmaceutici | 3,72 Mrd CHF | 21x | -0,65 | 74,45 CHF | -1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 2,5% Rialzo | Fai l’upgrade a Pro+ | |
Dottikon Es Holding AG | Svizzera | Salute | Prodotti farmaceutici | 3,60 Mrd CHF | 44,5x | -5,44 | 259 CHF | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Lepu Medical Tech Beijing DRC | Svizzera | Salute | Attrezzature e forniture medicali | 2,92 Mrd CHF | 21x | -0,44 | 13,70 CHF | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Joincare Pharmaceutical DRC | Svizzera | Salute | Prodotti farmaceutici | 2,66 Mrd CHF | 13,4x | -2,38 | 6,73 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medacta | Svizzera | Salute | Attrezzature e forniture medicali | 2,46 Mrd CHF | 46,6x | 3,62 | 125 CHF | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,4% Rialzo | Fai l’upgrade a Pro+ | |
BB Biotech | Svizzera | Salute | Ricerca medica e biotecnologica | 2,01 Mrd CHF | 8,6x | 0,02 | 36,40 CHF | -1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
SKAN | Svizzera | Salute | Attrezzature e forniture medicali | 1,78 Mrd CHF | 55,9x | 3,08 | 79,70 CHF | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 12,6% Rialzo | Fai l’upgrade a Pro+ | |
COSMO Pharma | Svizzera | Salute | Prodotti farmaceutici | 1,21 Mrd CHF | 18,4x | 0,03 | 75,10 CHF | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,1% Rialzo | Fai l’upgrade a Pro+ | |
Aevis Victoria | Svizzera | Salute | Fornitori e servizi sanitari | 1,18 Mrd CHF | -40,2x | 0,02 | 14 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
PolyPeptide Group AG | Svizzera | Salute | Prodotti farmaceutici | 1,05 Mrd CHF | -41,6x | -1,79 | 30,50 CHF | -3,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -1,6% Ribasso | Fai l’upgrade a Pro+ | |
Medartis | Svizzera | Salute | Attrezzature e forniture medicali | 786,34 Mln CHF | 187,5x | 1,25 | 57,90 CHF | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Kuros Biosciences | Svizzera | Salute | Ricerca medica e biotecnologica | 684,07 Mln CHF | -59,9x | -2,48 | 18,32 CHF | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Basilea Pharmaceutica AG | Svizzera | Salute | Ricerca medica e biotecnologica | 560,60 Mln CHF | -856,5x | 8,54 | 46,35 CHF | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 43,6% Rialzo | Fai l’upgrade a Pro+ |